| 发明名称 |
NOVEL THERAPEUTIC USE OF VIRAL INFLAMMATION MODULATORY PROTEIN IN BLOCKING XENOGRAFT REJECTION |
| 摘要 |
<p>The present invention provides a method of blocking xenograft rejection in a patient in need of such treatment by administering to said patient a virally-encoded complement control protein, referred to as the inflammation modulatory protein (<i>IMP</i>). The present invention further provides pharmaceutical compositions for the prevention or treatment of xenograft rejection comprising the IMP protein, alone or in combination with other immunosuppressive agents.</p> |
| 申请公布号 |
EP1185283(B1) |
申请公布日期 |
2005.09.07 |
| 申请号 |
EP20000936234 |
申请日期 |
2000.05.24 |
| 申请人 |
KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTRE;UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. |
发明人 |
KOTWAL, GIRISH, J.;AL-MOHANNA, FUTWAN;PARHAR, RANJIT |
| 分类号 |
A61K38/11;A61K38/16;(IPC1-7):A61K38/00;A61P37/06 |
主分类号 |
A61K38/11 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
